PMID- 27774933 OWN - NLM STAT- MEDLINE DCOM- 20170613 LR - 20171116 IS - 1007-8738 (Print) IS - 1007-8738 (Linking) VI - 32 IP - 11 DP - 2016 Nov TI - [Acquirement of autologous murine cytotoxic T lymphocytes via cryopreservation of lymphocytes]. PG - 1453-1457 AB - Objective To evaluate the effects of cryopreservation on the proliferation and killing activity of lymphocytes, and explore a novel protocol of preparing autologous mouse cytotoxic T lymphocytes (CTLs). Methods Mononuclear cells derived from spleen (5.0x10(6)/mL) were cryopreserved in CELLBANKER2 for 6 days and recovered in water bath at 39DegreesCelsius. The fresh lymphocytes and post-cryopreservation lymphocytes were induced by CD3 mAb (100 ng/mL) and recombinant mouse interleukin 2 (rmIL-2, 100 ng/mL) to obtain cytokine-induced killer cells (CIKs). Dendritic cells (DCs) were co-cultured with fresh allogenic lymphocytes and post-cryopreservation autologous lymphocytes to obtain CTLs. The viable cells were counted by trypan blue staining; the percentages of CD3(+)T cells and regulatory T cells (Tregs) were determined by flow cytometry; the levels of supernatant IFN-gamma were detected through ELISA and the cytotoxicity was evaluated by lactate dehydrogenase (LDH) assay. Results The rate of viable lymphocytes declined to 78% after cryopreservation, and there were no significant differences in the percentages of CD3(+)T cells and Tregs between pre-cryopreservation and post-cryopreservation. There were no significant differences in the proliferation of Tregs, the level of IFN-gamma and the cytotoxicity between the fresh CIKs and cryopreservation CIKs, and the similar results were get between the autologous CTLs and allogenic CTLs. Conclusion The autologous CTLs acquired via cryopreservation of lymphocytes is equivalent to the allogenic CTLs with the similar proliferation and killing activity in vitro. FAU - Wang, Lei AU - Wang L AD - Zhongnan Hospital, Institute of Liver and Gallbladder Disease, Transplant Center, Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan 430071, China. FAU - Peng, Na AU - Peng N AD - Zhongnan Hospital, Institute of Liver and Gallbladder Disease, Transplant Center, Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan 430071, China. FAU - Hu, Xiaoyan AU - Hu X AD - Zhongnan Hospital, Institute of Liver and Gallbladder Disease, Transplant Center, Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan 430071, China. FAU - Liang, Wentao AU - Liang W AD - Institute of General Surgery, Chinese PLA General Hospital, Beijing 100853, China. FAU - Liang, Kai AU - Liang K AD - Institute of General Surgery, Chinese PLA General Hospital, Beijing 100853, China. FAU - Peng, Guizhu AU - Peng G AD - Zhongnan Hospital, Institute of Liver and Gallbladder Disease, Transplant Center, Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Wuhan 430071, China. *Corresponding author, E-mail: pengguizhu@139.com. LA - chi PT - Journal Article PL - China TA - Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi JT - Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology JID - 101139110 RN - 0 (CD3 Complex) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Animals MH - CD3 Complex/metabolism MH - Cells, Cultured MH - Cryopreservation/*methods MH - Cytotoxicity, Immunologic MH - Dendritic Cells/cytology/metabolism MH - Interferon-gamma/metabolism MH - Lymphocytes/*cytology/immunology MH - Mice MH - T-Lymphocytes/cytology/immunology MH - T-Lymphocytes, Cytotoxic/*cytology/immunology EDAT- 2016/10/25 06:00 MHDA- 2017/06/14 06:00 CRDT- 2016/10/25 06:00 PHST- 2016/10/25 06:00 [pubmed] PHST- 2017/06/14 06:00 [medline] PHST- 2016/10/25 06:00 [entrez] PST - ppublish SO - Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2016 Nov;32(11):1453-1457.